上海雅吉生物科技有限公司
首页 产品目录 产品目录(简版) 公司动态 企业认证 企业体检 公司相册 联系我们

文献引用产品:人胰腺管癌细胞Capan-1

发布人:上海雅吉生物科技有限公司

发布日期:2026/4/13 8:47:46

文章标题:SPHK1 Promotes Pancreatic Cancer Lymphangiogenesis Through the Activation of ERK in LECs

期刊:MOLECULAR BIOTECHNOLOGY
作者列表:Yu Mengsi, Wang Song, Zeng Yujie, Liu Pingli, Li Hui
发表时间:2024-6-11
影响因子:2.4
DOI:10.1007/s12033-024-01192-9
主要研究成果Abstract
Lymphatic metastasis is related to an unsatisfactory prognosis in pancreatic cancer. Sphingosine kinase 1 (SPHK1) is an oncogene in cancer. However, the potential effect of SPHK1 on the lymphangiogenesis of pancreatic cancer is little known. In this study, the expression level and role of SPHK1 in pancreatic cancer were evaluated to explore the underlying mechanism involved. The expression of SPHK1 and the lymphatic vessel density (LVD) in pancreatic cancer patient tissue were investigated by immunohistochemistry. The role of SPHK1 in lymphangiogenesis was verified in vitro. Elevated expression of SPHK1 was strongly related to high LVD in pancreatic cancer patient tissue. Silencing of SPHK1 in pancreatic cancer cells observably inhibited lymphangiogenesis. Furthermore, the downregulation of SPHK1 markedly attenuated the phosphorylation of extracellular signal-regulated kinase in lymphatic endothelial cells. This study revealed that SPHK1 might play a crucial role in pancreatic cancer lymphangiogenesis.


相关新闻资讯

文献引用产品:人宫颈癌细胞HeLa

2026/04/13

 文章标题:miR-34a-5p blocks cervical cancer growth and migration by downregulating CDC25A.期刊:Journal of BUON作者列表:Jiang T, Cheng H发表时间:2021-9-1影响因子:2.533DOI:PMID:34761581主要研究成果Abstract PurposeTo define mec

文献引用产品:人子宫颈表皮癌细胞ME-180

2026/04/13

 文章标题:miR-34a-5p blocks cervical cancer growth and migration by downregulating CDC25A.期刊:Journal of BUON作者列表:Jiang T, Cheng H发表时间:2021-9-1影响因子:2.533DOI:PMID:34761581主要研究成果Abstract PurposeTo define mec

文献引用产品:End1/E6E7人子宫颈内膜细胞

2026/04/13

 文章标题:METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling期刊:HEREDITAS作者列表:Pu Mei, Xiao Xia, Lv Shasha, Ran Daqing, Huang Qian, Zhou Ming